(RNR) Renaissancere Holdings - Ratings and Ratios
Exchange: NYSE • Country: Bermuda • Currency: USD • Type: Common Stock • ISIN: BMG7496G1033
RNR: Reinsurance, Insurance, Property, Casualty, Specialty
RenaissanceRe Holdings Ltd. (NYSE: RNR) stands as a prominent figure in the global reinsurance sector, renowned for its specialized expertise in catastrophe risk management. Established in 1993 and headquartered in Pembroke, Bermuda, the company has carved a niche for itself through its sophisticated underwriting strategies and a disciplined approach to risk assessment. Its operations are divided into two core segments: Property and Casualty and Specialty.
The Property segment is dedicated to providing catastrophe reinsurance solutions, offering protection against a myriad of natural and man-made disasters, including hurricanes, earthquakes, and tsunamis. This segment also encompasses a range of proportional reinsurance products, underscoring the companys comprehensive approach to risk mitigation in the property sector.
The Casualty and Specialty segment diversifies the companys offerings, covering a broad spectrum of liability products. This includes directors and officers liability, medical malpractice, and professional indemnity, alongside general liability and workers compensation. Additionally, the segment extends into emerging areas such as cyber and energy risks, showcasing RenaissanceRes adaptability and foresight in a dynamic market.
RenaissanceRes distribution network primarily relies on intermediaries, ensuring efficient access to a wide range of clients globally. The companys investment management arm further enhances its value proposition, leveraging advanced strategies to optimize returns and bolster its financial resilience.
With a market capitalization of approximately $11.67 billion, RenaissanceRe demonstrates strong financial fundamentals. The companys P/E ratio of 6.61 and forward P/E of 7.81 indicate a favorable valuation, supported by a price-to-book ratio of 1.22 and a price-to-sales ratio of 0.92. These metrics highlight RenaissanceRes attractiveness to investors seeking stability and growth in the reinsurance sector.
Additional Sources for RNR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RNR Stock Overview
Market Cap in USD | 12,008m |
Sector | Financial Services |
Industry | Insurance - Reinsurance |
GiC Sub-Industry | Reinsurance |
IPO / Inception | 1995-07-26 |
RNR Stock Ratings
Growth 5y | 58.5% |
Fundamental | 77.8% |
Dividend | 51.7% |
Rel. Strength Industry | -13.8 |
Analysts | 3.25/5 |
Fair Price Momentum | 226.07 USD |
Fair Price DCF | 1954.01 USD |
RNR Dividends
Dividend Yield 12m | 0.65% |
Yield on Cost 5y | 1.12% |
Annual Growth 5y | 2.19% |
Payout Consistency | 99.3% |
RNR Growth Ratios
Growth Correlation 3m | -73.6% |
Growth Correlation 12m | 60.4% |
Growth Correlation 5y | 75.2% |
CAGR 5y | 11.66% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.57 |
Alpha | 0.29 |
Beta | 0.15 |
Volatility | 24.61% |
Current Volume | 592.5k |
Average Volume 20d | 452.2k |
As of March 11, 2025, the stock is trading at USD 241.45 with a total of 592,464 shares traded.
Over the past week, the price has changed by +0.07%, over one month by +3.17%, over three months by -10.14% and over the past year by +3.36%.
Yes, based on ValueRay Fundamental Analyses, Renaissancere Holdings (NYSE:RNR) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 77.76 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RNR as of March 2025 is 226.07. This means that RNR is currently overvalued and has a potential downside of -6.37%.
Renaissancere Holdings has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold RNR.
- Strong Buy: 2
- Buy: 2
- Hold: 6
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, RNR Renaissancere Holdings will be worth about 244.4 in March 2026. The stock is currently trading at 241.45. This means that the stock has a potential upside of +1.21%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 276.2 | 14.4% |
Analysts Target Price | 289.8 | 20% |
ValueRay Target Price | 244.4 | 1.2% |